Johan Giesecke

Johan Giesecke

Auto-generated profile, based on publicly available information

Johan Giesecke

European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2005 in Emerging Infectious Diseases
Verified
Journal Article
Open access
LPLara Payne
Lara Payne
MAMalin Arneborn
Malin Arneborn
ATAnders Tegnell
Anders Tegnell
JGJohan Giesecke
Johan Giesecke
Tularemia cases have been reported in Sweden since 1931, but no cyclical patterns can be identified. In 2003, the largest outbreak of tularemia since 1967 occurred, involving 698 cases. Increased reports were received from tularemia-nonendemic areas. Causal factors for an outbreak year and associated geographic distribution are not yet understood.

17 May 2012 in Eurosurveillance
Verified
Journal Article
Open access
DDD Domanovic
D Domanovic
JGJ Giesecke
J Giesecke
Eurosurveillance.org is the online home of Eurosurveillance, Europe's journal on infectious disease surveillance, epidemiology, prevention and control.

5 February 2022 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
ESEttore Severi
Ettore Severi
LGLeonidas Georgalis
Leonidas Georgalis
RPRoan Pijnacker
Roan Pijnacker
LVLamprini Veneti
Lamprini Veneti
ITIulia Adelina Turiac
Iulia Adelina Turiac
JGJohan Giesecke
Johan Giesecke

1 October 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
KWK Widgren
K Widgren
LBL Persson Berg
L Persson Berg
AMA Mörner
A Mörner
LLL Lindquist
L Lindquist
ATA Tegnell
A Tegnell
MSM Studahl
M Studahl
To describe the current panorama of severe chickenpox disease and seroprevalence in Sweden, as a basis for the approaching decision on universal vaccination. Patients discharged with an International Classification of Diseases 10th revision-code for chickenpox (B01-B01.9) in eight pediatric and infectious diseases departments in Stockholm and Gothenburg in 2012-2014 were included in the study and their medical charts were reviewed. Further, residual serum samples collected from 11 laboratories across Sweden were analyzed for varicella zoster IgG-antibodies to investigate age-specific seroprevalence. A total of 218 children and 46 adults were included in this hospital-based study; 87.2% of children and 63.0% of adults had complications. An underlying condition was not associated with an increased risk of complication. Dehydration (31.7%), bacterial skin infections (29.8%) and neurological involvement (20.6%) were the most frequent complications in children. Among adult cases, 63% were born abroad. The seroepidemiological analysis included 957 patient samples. Seroprevalence was 66.7% at 5 years and 91.5% at 12 years. Infants and adolescents/adults were overrepresented among admitted patients compared to seroprevalence data. Half of all complications in hospitalized chickenpox cases were seen in previously healthy children, which supports universal childhood vaccination. Adult migrants was a risk group for chickenpox hospitalization. Age-specific seroprevalence was similar to neighboring countries.

13 September 2009 in Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
Verified
Journal Article
Closed access
PDF file
PLPier Luigi Lopalco
Pier Luigi Lopalco
HCH.G. de Carvalho
H.G. de Carvalho
Peter KreidlPeter Kreidl
Peter Kreidl
KLK. Leitmeyer
K. Leitmeyer
JGJ. Giesecke
J. Giesecke

19 January 2012 in Eurosurveillance
Verified
Journal Article
Open access
FFF Forland
F Forland
HGH De Carvalho Gomes
H De Carvalho Gomes
HNH Nokleby
H Nokleby
AEA Escriva
A Escriva
DCD Coulombier
D Coulombier
AJAnita Jansen
Anita Jansen
With reference to the Q fever outbreak in the Netherlands in 2009-10, we tested if an evidence-based approach, comparable to the methodology used in clinical medicine, was appropriate for giving public health advice under time constrains. According to the principles of evidence-based methodologies, articles were retrieved from bibliographic databases and categorised by type and size, outcome, strengths and limitations. The risk assessment was conducted in two months and involved six staff members. We retrieved and read 559 abstracts and selected approximately 150 full text articles. The most striking finding was the lack of sound scientific evidence behind standard treatment regimes for Q fever in pregnancy. Difficulties in applying existing evidence rating systems and in expressing uncertainties were identified as problems during the process. By systematically assessing the evidence on several questions about Q fever, we were able to draw new conclusions and specify earlier statements. We found it difficult to grade the mostly observational studies with the known evidence-based grading systems. There is need to develop new methods for grading evidence from different sources in the field of public health. We conclude that an evidence-based approach is feasible for providing a risk assessment within two to three months.